14 October 2012
RPCI researchers recently participated in a landmark study that provided insights into the different types of breast cancer and the genetic factors involved in their development. Christine Ambrosone, PhD, Chair of the Department of Cancer Prevention and Control, Stephen Edge, MD, FACS, Medical Director of the Breast Center and Chief of Breast Surgery, and Carl Morrison, MD, DVM, Clinical Chief of the Department of Pathology & Laboratory Medicine, take part in a multidisciplinary discussion about this research and how it will impact the future of cancer treatment.